216 related articles for article (PubMed ID: 2396604)
1. Effect of clot-detection methods and reagents on activated partial thromboplastin time (APTT). Implications in heparin monitoring by APTT.
D'Angelo A; Seveso MP; D'Angelo SV; Gilardoni F; Dettori AG; Bonini P
Am J Clin Pathol; 1990 Sep; 94(3):297-306. PubMed ID: 2396604
[TBL] [Abstract][Full Text] [Related]
2. Comparison of two automated coagulometers and the manual tilt-tube method for the determination of prothrombin time.
D'Angelo A; Seveso MP; D'Angelo SV; Gilardoni F; Macagni A; Manotti C; Bonini P
Am J Clin Pathol; 1989 Sep; 92(3):321-8. PubMed ID: 2773851
[TBL] [Abstract][Full Text] [Related]
3. Variation among commercial activated partial thromboplastin time reagents in response to heparin.
Shapiro GA; Huntzinger SW; Wilson JE
Am J Clin Pathol; 1977 May; 67(5):477-80. PubMed ID: 857645
[TBL] [Abstract][Full Text] [Related]
4. Use of a fixed activated partial thromboplastin time ratio to establish a therapeutic range for unfractionated heparin.
Bates SM; Weitz JI; Johnston M; Hirsh J; Ginsberg JS
Arch Intern Med; 2001 Feb; 161(3):385-91. PubMed ID: 11176764
[TBL] [Abstract][Full Text] [Related]
5. The therapeutic range for heparin therapy: relationship between six activated partial thromboplastin time reagents and two heparin assays.
Kitchen S; Preston FE
Thromb Haemost; 1996 May; 75(5):734-9. PubMed ID: 8725715
[TBL] [Abstract][Full Text] [Related]
6. Effect of heparin on whole blood activated partial thromboplastin time using a portable, whole blood coagulation monitor.
Despotis GJ; Hogue CW; Santoro SA; Joist JH; Barnes PW; Lappas DG
Crit Care Med; 1995 Oct; 23(10):1674-9. PubMed ID: 7587232
[TBL] [Abstract][Full Text] [Related]
7. Variability in heparin sensitivity of APTT reagents.
Bjornsson TD; Nash PV
Am J Clin Pathol; 1986 Aug; 86(2):199-204. PubMed ID: 3739971
[TBL] [Abstract][Full Text] [Related]
8. Heparin monitoring by activated partial thromboplastin time. Comparison of ex vivo measurement and in vitro standardization.
Scialla SJ
Am J Clin Pathol; 1985 Sep; 84(3):351-4. PubMed ID: 4036867
[TBL] [Abstract][Full Text] [Related]
9. Bedside coagulometry during intravenous heparin therapy after coronary angioplasty.
Schroeder AP; Knudsen LL; Husted SE; Knudsen L; Ingerslev J
J Thromb Thrombolysis; 2001 Oct; 12(2):157-63. PubMed ID: 11729367
[TBL] [Abstract][Full Text] [Related]
10. Monitoring heparin therapy using activated partial thromboplastin time--results of a multicenter trial establishing the therapeutic range for SILIMAT, a reagent with high sensitivity to heparin.
Toulon P; Boutière B; Horellou MH; Trzeciak MC; Samama MM
Thromb Haemost; 1998 Jul; 80(1):104-8. PubMed ID: 9684794
[TBL] [Abstract][Full Text] [Related]
11. The effect of aprotinin on the response of the activated partial thromboplastin time (APTT) to heparin.
Francis JL; Howard C
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):35-40. PubMed ID: 7681330
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Q analyzer, a new cap-piercing fully automated coagulometer with clotting, chromogenic, and immunoturbidometric capability.
Kitchen S; Woolley A
Blood Coagul Fibrinolysis; 2013 Jan; 24(1):28-34. PubMed ID: 23249565
[TBL] [Abstract][Full Text] [Related]
13. A study of atypical APTT derivative curves on the ACL TOP coagulation analyser.
Solano C; Zerafa P; Bird R
Int J Lab Hematol; 2011 Feb; 33(1):67-78. PubMed ID: 20649909
[TBL] [Abstract][Full Text] [Related]
14. Heparin in vitro sensitivity of the activated partial thromboplastin time in canine plasma depends on reagent.
Mischke R
J Vet Diagn Invest; 2003 Nov; 15(6):588-91. PubMed ID: 14667026
[TBL] [Abstract][Full Text] [Related]
15. Standardization of coagulation tests.
Opartkiattikul N
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
[TBL] [Abstract][Full Text] [Related]
16. Use of an automated coagulation analyzer to perform heparin neutralization with polybrene in blood samples for routine coagulation testing: practical, rapid, and inexpensive.
Tientadakul P; Kongkan C; Chinswangwatanakul W
Arch Pathol Lab Med; 2013 Nov; 137(11):1641-7. PubMed ID: 24168503
[TBL] [Abstract][Full Text] [Related]
17. Recommendations for appropriate activated partial thromboplastin time reagent selection and utilization.
Fritsma GA; Dembitzer FR; Randhawa A; Marques MB; Van Cott EM; Adcock-Funk D; Peerschke EI
Am J Clin Pathol; 2012 Jun; 137(6):904-8. PubMed ID: 22586049
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of cumulative summation of differences method for determining APTT reagent suitability.
Findlater SH
Clin Lab Sci; 2012; 25(3):142-8. PubMed ID: 22953513
[TBL] [Abstract][Full Text] [Related]
19. An attempt to standardize the APTT for heparin monitoring, using the P.T. ISI/INR system of calibration. Results of a 13 centre study.
Reed SV; Haddon ME; Denson KW
Thromb Res; 1994 Jun; 74(5):515-22. PubMed ID: 8085252
[TBL] [Abstract][Full Text] [Related]
20. Monitoring of unfractionated heparin with the activated partial thromboplastin time: determination of therapeutic ranges.
van den Besselaar AM; Sturk A; Reijnierse GL
Thromb Res; 2002 Sep; 107(5):235-40. PubMed ID: 12479884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
